Drug Shortage Report for ERYTHRO-ES

Last updated on 2020-08-06 History
Report ID 3752
Drug Identification Number 00637416
Brand name ERYTHRO-ES
Common or Proper name ERYTHRO-ES
Company Name AA PHARMA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ERYTHROMYCIN
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 Bottle
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2015-06-24
Actual start date
Estimated end date Unknown
Actual end date 2019-01-15
Shortage status Resolved
Updated date 2020-08-06
Company comments product discontinued
Health Canada comments
Contact Address 1165 CREDITSTONE ROAD
VAUGHAN, ONTARIO
CANADA L4K 4N7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-08-06 French Compare
v3 2020-08-06 English Compare
v2 2017-03-21 French Compare
v1 2017-03-21 English Compare